zoloft 50 mg apvalkotās tabletes
upjohn eesv, netherlands - sertralīns - apvalkotā tablete - 50 mg
midazolam kalceks 1 mg/ml šķīdums injekcijām/infūzijām
kalceks, a/s, latvia - midazolāms - Šķīdums injekcijām/infūzijām - 1 mg/ml
endoxan 50 mg apvalkotās tabletes
baxter sas, france - ciklofosfamīds - apvalkotā tablete - 50 mg
zoloft 50 mg apvalkotās tabletes
upjohn eesv, netherlands - sertralīns - apvalkotā tablete - 50 mg
orserdu
stemline therapeutics b.v. - elacestrant - krūts audzējs - endokrīnā terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.